The combination of exosomes and circulating miRNAs (miR-10b, miR-21, miR-122 and miR-200a) may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage HCC [16]. This evidence concerns the gene AFP and hepatocellular carcinoma.